Is minimal residual disease (MRD) testing routinely recommended?

In this week’s video, Dr. Durie discusses when testing for minimal residual disease (MRD) is applicable, and the different methods of testing available.


The BOTTOM LINE:



Outside of clinical trials, MRD testing is not routinely recommended.

Please subscribe to our channel!


Subscribe to International Myeloma Foundation:



Visit our website at:



Find us online:

Facebook:

Google+:

IMF on twitter: @IMFMyeloma (

Dr. Durie on twitter: @BrianDurieMD (



Support the IMF!

Category

Nonprofits & Activism

License

Standard YouTube License

myeloma,multiple myeloma,cancer,bone marrow cancer,cancer treatment,cancer research,bone disease,dr brian durie,susie novis,bone marrow,multiple myeloma cancer,bone cancer,bone marrow disease,blood cancer,blood plasma cancer,yt:cc=on,